RecruitingNot applicableNCT06864351
Prospective Evaluation of OptiThyDose
Studying Congenital hypothyroidism
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University Children's Hospital Basel
- Principal Investigator
- Gabor Szinnai, Prof. MD, PhDPaediatric Endocrinology, UKBB
- Intervention
- OptiThyDose(other)
- Enrollment
- 150 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2025 – 2029
Study locations (2)
- Department of Paediatric Endocrinology, Diabetology and Gynaecology, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris, France
- Paediatric Endocrinology and Diabetology, University Children's Hospital Basel (UKBB), Basel, Canton of Basel-City, Switzerland
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06864351 on ClinicalTrials.govOther trials for Congenital hypothyroidism
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07280104Infants With Primary Congenital Hypothyroidism and DevelopmentNigde Omer Halisdemir University
- ENROLLING BY INVITATIONNANCT06864039Quality of Life and Long-term Outcome of Adequately Treated Congenital HypothyroidismFederico II University
- RECRUITINGNCT06724224Comparison of Levothyroxine Formulations in the Treatment of Congenital HypothyroidismIRCCS Azienda Ospedaliero-Universitaria di Bologna
- RECRUITINGNCT05581147Thyroid Function and Structure in Klinefelter SyndromeUniversity of Roma La Sapienza